Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

ENDRA Life Sciences (NDRA) Other Non Operating Income (2017 - 2021)

ENDRA Life Sciences (NDRA) has disclosed Other Non Operating Income for 6 consecutive years, with -$350145.0 as the latest value for Q4 2021.

  • Quarterly Other Non Operating Income changed N/A to -$350145.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was -$49052.0 through Dec 2021, down 1327.53% year-over-year, with the annual reading at $3.1 million for FY2024, 568.14% up from the prior year.
  • Other Non Operating Income for Q4 2021 was -$350145.0 at ENDRA Life Sciences, down from -$7507.0 in the prior quarter.
  • The five-year high for Other Non Operating Income was $308600.0 in Q1 2021, with the low at -$380926.0 in Q1 2017.
  • Average Other Non Operating Income over 5 years is -$36422.6, with a median of -$8353.0 recorded in 2019.
  • The sharpest move saw Other Non Operating Income tumbled 6225.57% in 2017, then soared 4563.74% in 2021.
  • Over 5 years, Other Non Operating Income stood at $1931.0 in 2017, then tumbled by 979.85% to -$16990.0 in 2018, then tumbled by 203.56% to -$51575.0 in 2019, then surged by 94.92% to -$2621.0 in 2020, then plummeted by 13259.21% to -$350145.0 in 2021.
  • According to Business Quant data, Other Non Operating Income over the past three periods came in at -$350145.0, -$7507.0, and $308600.0 for Q4 2021, Q3 2021, and Q1 2021 respectively.